Paladin Labs Inc.

Paladin Labs Inc.

December 11, 2013 09:41 ET

Paladin Labs Inc.: Endo Health Solutions Files Draft Proxy Statements/Prospectus

MONTREAL, CANADA--(Marketwired - Dec. 11, 2013) -


Paladin Labs Inc. (TSX:PLB) today announced that, in connection with the transaction announced on November 5, 2013 with Endo Health Solutions (NASDAQ:ENDP), Endo has filed a draft proxy statement/prospectus with the United States Securities and Exchange Commission (the SEC). Following the review of the proxy statement/prospectus by the SEC, the proxy statement/prospectus will be mailed to shareholders of Endo in connection with a special meeting to be held to approve the transaction. Paladin will mail its own circular to its shareholders on or about the same day in connection with its special meeting to be held to approve the transaction. The draft proxy statement/prospectus and revised drafts will be available under Endo's profile at the website As the draft proxy statement/prospectus of Endo includes information about the transaction and the parties, for the sake of convenience of its shareholders, Paladin is also making the draft and subsequent drafts available under its SEDAR profile at

About Paladin Labs Inc.

Paladin Labs Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets. With this strategy, a focused national sales team and proven marketing expertise, Paladin has evolved into one of Canada's leading specialty pharmaceutical companies. Paladin's shares trade on the Toronto Stock Exchange under the symbol PLB. For more information about Paladin, please visit the Company's web site at

Forward Looking Statements

This press release may contain forward-looking statements and predictions. These forward-looking statements, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. The Company considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared, but cautions that these assumptions regarding the future events, many of which are beyond the control of the Company and its subsidiaries, may ultimately prove to be incorrect. Factors and risks, which could cause actual results to differ materially from current expectations, are discussed in the annual report as well as in the Company's Annual Information Form for the year ended December 31, 2012. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information or future events and except as required by law. For additional information on risks and uncertainties relating to these forward-looking statements, investors should consult the Company's ongoing quarterly fillings, annual report and Annual Information Form and other fillings found on SEDAR at

Contact Information